Posters

Six-month clinical outcomes of new trifocal intraocular lenses using the sinusoidal pattern with enhanced depth of focus

Poster Details

First Author: M.Tomita JAPAN

Co Author(s):                        

Abstract Details

Purpose:

Acriva Trinova lens (VSY Biotechnology, Netherland) is the new model of trifocal lens with sinusoidal pattern and Enhanced Depth of focus (EDOF). To evaluate clinical outcomes of Acriva Trinova lens, we analyzed clinical outcome of Acriva Trinova lens.

Setting:



Setting:

Minoru Tomita Eye Clinic Ginza, Tokyo, Japan

Methods:

In this study, 144 eyes were implanted with Acriva Trinova lenses. The outcomes of Uncorrected Distance Visual Acuity (UDVA), Uncorrected Intermediate Visual Acuity (UIVA), Uncorrected Near Visual Acuity (UNVA), Corrected Distance Visual Acuity (CDVA), Corrected Near Visual Acuity (CNVA), and MRSE (Manifest Refraction (sphere, cylinder and spherical equivalent (SE)) were measured and compared pre-operatively and 6 months post-operatively. The pre-operative UDVA, CDVA, UNVA, CNVA, and UIVA were 20/200, 20/30, J11, J4, and 20/70. Preoperative MRSE was -4.97±5.66D. All surgeries were used FLACS (femtosecond laser-assisted cataract surgery) with Femto LDVZ8 (Ziemer, Switzerland) and Centurion (Alcon, USA).

Results:

At post-operative 6 months, UDVA, CDVA, UNVA, CNVA, and UIVA were 20/16, 20/16, J2, J1, and 20/20. Postoperative MRSE was 0.43±0.38D at 6 months. No intraoperative or postoperative complications were observed. UDVA, CDVA, UNVA, CNVA, and UIVA were significantly improved at post-operative 6 months (p<0.01).

Conclusions:

The clinical outcomes of Acriva Trinova lens showed significant improvement of UDVA, UNVA, and UIVA. This study showed the sinusoidal pattern with EDOF lens was safe and effective for cataract patients.

Financial Disclosure:

None